Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | PER2 | O15055 | 1/20 | 0.36 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21485040 | 0.79 | PER2 (0.36) | MEN1KMT2AALDH1A1PER2CRY2 | |
| SCHEMBL2725698 | 0.76 | PIK3CD (0.53) | PIK3CDKMT2APER2TSHR | |
| SCHEMBL13966300 | 0.75 | TSHR (0.35) | PIK3CDKDM4EALDH1A1HPGDPER2 | |
| SCHEMBL27621187 | 0.74 | MEN1 (0.57) | MEN1KMT2AL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL354341 | 0.72 | TSHR (0.41) | KDM4EALDH1A1HPGDTSHRNAAA | |
| SCHEMBL152211 | 0.72 | TSHR (0.40) | MEN1KMT2AALDH1A1HPGDTSHR | |
| Acrylic Acid SCHEMBL29142700 | 0.72 | KDM4E (0.39) | PIK3CDKDM4E | |
| SCHEMBL3177915 | 0.72 | PIK3CD (0.58) | PIK3CDKDM4EPER2CRY2NAAA | |
| SCHEMBL11315322 | 0.72 | TSHR (0.37) | MEN1KMT2AL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL12413745 | 0.71 | PIK3CD (0.79) | PIK3CDKDM4EPER2CRY2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2406239-B1 | CYCLIC CARBAMATE COMPOUNDS USEFUL IN ENERGY-CURABLE COMPOSITIONS | SUN CHEMICAL BV (NL) | 2016-09-14 | — | — | EP | disclosed |
| US-9428471-B2 | Cyclic carbamate compounds useful in energy-curable compositions | SUN CHEMICAL B.V. (NL) | 2016-08-30 | — | — | US | disclosed |
| US-20120015159-A1 | CYCLIC CARBAMATE COMPOUNDS USEFUL IN ENERGY-CURABLE COMPOSITIONS | SUN CHEMICAL B.V. (NL) | 2012-01-19 | — | — | US | disclosed |
| EP-2406239-A1 | CYCLIC CARBAMATE COMPOUNDS USEFUL IN ENERGY-CURABLE COMPOSITIONS | Sun Chemical B.V. (NL) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010103281-A1 | CYCLIC CARBAMATE COMPOUNDS USEFUL IN ENERGY-CURABLE COMPOSITIONS | SUN CHEMICAL B.V. (NL) | 2010-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015159-A1 | CYCLIC CARBAMATE COMPOUNDS USEFUL IN ENERGY-CURABLE COMPOSITIONS | ACMSD, PYCARD, DNMT3L | PIK3CD 508/4885MEN1 2543/4885KMT2A 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.